Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.

Autor: Padmapriyadarsini C; Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Oswal VS; DRTB Site, Pandit Malviya Shatabdi Centenary Hospital, Mumbai, India., Jain CD; DRTB DOTS Plus Site, Sarvodaya Charitable Trust Hospital, Mumbai, India., Mariappan MV; Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Singla N; Department of Epidemiology and Public Health, National Institute for Tuberculosis and Respiratory Diseases, New Delhi, India., Kumar S; Department of Pulmonary Medicine, Sarojini Naidu Medical College, Agra, India., Daniel BD; Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Dave JD; Department of Respiratory Medicine, Government Medical College, Bhavnagar, India., Vadgama P; Department of Respiratory Medicine, Government Medical College, Surat, India., Ramraj B; Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Kant S; Department of Respiratory Medicine, King George's Medical University, Lucknow, India., Bhatnagar AK; Department of Chest and TB Rajan Babu Institute of Pulmonary Medicine and Tuberculosis, Delhi, India., Shanmugam S; Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Paul D; Department of Respiratory Medicine, Government Rajaji Hospital, Madurai, India., Bharathi J; Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Palav M; DRTB Site, Pandit Malviya Shatabdi Centenary Hospital, Mumbai, India., Shah NV; DRTB DOTS Plus Site, Sarvodaya Charitable Trust Hospital, Mumbai, India., Santhanakrishnan R; Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Dewan RK; Department of Epidemiology and Public Health, National Institute for Tuberculosis and Respiratory Diseases, New Delhi, India., Shekh N; Department of Pulmonary Medicine, Sarojini Naidu Medical College, Agra, India., Rathinam P; Department of Respiratory Medicine, Government Rajaji Hospital, Madurai, India., Sisara AB; Department of Respiratory Medicine, Government Medical College, Bhavnagar, India., Mankar SD; DRTB Site, Pandit Malviya Shatabdi Centenary Hospital, Mumbai, India., Bajpai J; Department of Respiratory Medicine, King George's Medical University, Lucknow, India., Mittal U; Department of Chest and TB Rajan Babu Institute of Pulmonary Medicine and Tuberculosis, Delhi, India., Chauhan S; National Tuberculosis Elimination Programme, Central TB Division, New Delhi, India., Kumar R; National Tuberculosis Elimination Programme, Central TB Division, New Delhi, India., Parmar M; Drug-resistant TB, World Health Organization, India Office, New Delhi, India., Mattoo SK; National Tuberculosis Elimination Programme, Central TB Division, New Delhi, India., Jaju J; iDFFEAT TB Project, International Union Against Tuberculosis and Lung Disease, New Delhi, India.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 28. Date of Electronic Publication: 2024 Aug 28.